Advertisement

Topics

Topical bimatoprost for the treatment of eyebrow hypotrichosis.

06:00 EST 30th December 2011 | BioPortfolio

Summary of "Topical bimatoprost for the treatment of eyebrow hypotrichosis."

Topical bimatoprost was FDA approved in December of 2008 for the treatment of eyelash hypotrichosis. Since its approval, some physicians have advocated the use of bimatoprost "off label" for hair growth in other areas, such as the scalp or eyebrows, but there has yet to be published scientific evidence to support this use. We report one of the first cases of significant eyebrow hair growth in a patient after use of topical bimatoprost for eyebrow hypotrichosis. J Drugs Dermatol. 2012;11(1):106-108.

Affiliation

Journal Details

This article was published in the following journal.

Name: Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Pages: 106-8

Links

DeepDyve research library

PubMed Articles [18291 Associated PubMed Articles listed on BioPortfolio]

Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis.

Eyebrow loss may have substantial negative functional and social consequences.

Bimatoprost solution 0.03% topical application to the eyelid margin for the treatment of eyelash hypotrichosis.

Individuals with hair loss experience significant psycho-emotional stress, often causing impaired quality of life and secondary morbidity(1) . Loss of eyebrows and lashes affects self-identity due to ...

Isolated eyebrow loss in frontal fibrosing alopecia: relevance of early diagnosis and treatment.

Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia characterized by progressive loss of frontotemporal hairline and eyebrows that affects mainly postmenopausal women. Eyebr...

Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.

Although there are limited data available on gender as an outcome variable in the treatment of onychomycosis, differences in disease prevalence and impact in males versus females have been observed. T...

A review of patient adherence to topical therapies for treatment of atopic dermatitis.

Atopic dermatitis (AD) is one of the most commonly diagnosed dermatologic conditions in the United States. Topical agents are the mainstay of treatment for AD, and when used correctly, these therapies...

Clinical Trials [1287 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin

This one-year study evaluates the long-term safety and effectiveness of bimatoprost solution application to the eyelid margin (where the eyelashes meet the skin) to treat hypotrichosis of ...

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

This is a post-marketing surveillance study in Japan that will evaluate the safety and patient satisfaction with GLASH VISTA™ (bimatoprost cutaneous solution 0.03%) in the treatment of h...

Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasin...

Safety and Efficacy of Bimatoprost Solution in Treating Chemotherapy-induced Eyelash Loss or Hypotrichosis in Children

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily application to the upper eyelid margins compared with vehicle in treating eyelash loss or hypotric...

Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants

RATIONALE: Bimatoprost ophthalmic solution may help increase eyebrow and eyelash growth in patients who have undergone chemotherapy. PURPOSE: This randomized clinical trial is studying ho...

Medical and Biotech [MESH] Definitions

Rare autosomal dominant disorder of the hair shaft. The clinical features of the disease include HYPOTRICHOSIS, dry, and/or brittle hair, with varying degrees of ALOPECIA. Mutations in the hair-specific keratin genes KRTHB1, KRTHB3, or KRTHB6 are associated with monilethrix. Autosomal recessive monilethrix with limited HYPOTRICHOSIS are also known. Mutations in Dsg4, Liph, and P2ry5 protein genes are associated with the recessive form of monilethrix.

A topical glucocorticoid used in the treatment of ECZEMA.

A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects.

Fluorides, usually in pastes or gels, used for topical application to reduce the incidence of DENTAL CARIES.

Presence of less than the normal amount of hair. (Dorland, 27th ed)

Quick Search
Advertisement
 
DeepDyve research library

Searches Linking to this Article